Bristol-Myers Squibb Company
Triazolopyridine inhibitors of myeloperoxidase
Last updated:
Abstract:
The present invention provides compounds of Formula (I): ##STR00001## wherein A is as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.
Status:
Grant
Type:
Utility
Filling date:
30 Aug 2016
Issue date:
10 Sep 2019